Adjuvant Antibody Therapy with Trastuzumab in Early Breast Cancer

Benutzer: Gast

Autor(en):: Untch, Michael; Scharl, Anton; Jackisch, Christian; Thomssen, Christoph; Nitz, Ulrike; Minckwitz, Gunter von; Harbeck, Nadia
Titel:: Adjuvant Antibody Therapy with Trastuzumab in Early Breast Cancer
Abstract:: Immunotherapy with the monoclonal antibody trastuzumab is a well established cornerstone of an individualized treatment strategy for women with HER2/neu-overexpressing breast cancer. Based on the reported data of clinical studies comprising more than 14,000 women, trastuzumab was approved throughout the European Union in May 2006 for adjuvant therapy in patients with early-stage HER2/neu-overexpressing breast cancer.
Zeitschriftentitel:: Breast Care
Jahr:: 2006
Band / Volume:: 1
Heft / Issue:: 4
Seitenangaben Beitrag:: 252--255
Volltext / DOI:: doi:10.1159/000094891
Verlag / Institution:: S. Karger GmbH
Verlagsort:: Freiburg, Germany
Print-ISSN:: 1661-3805
E-ISSN:: 1661-3805
Hinweise:: Dieser Beitrag ist mit Zustimmung des Rechteinhabers aufgrund einer (DFG-geförderten) Allianz- bzw. Nationallizenz frei zugänglich. This publication is with permission of the rights owner freely accessible due to an Alliance licence and a national licence (funded by the DFG, German Research Foundation) respectively.
BibTeX

Vorkommen: